Your browser doesn't support javascript.
loading
Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care. / Paciente exacerbador con enfermedad pulmonar obstructiva crónica: recomendaciones en procesos diagnósticos, terapéuticos y asistenciales.
Alcázar Navarrete, Bernardino; Ancochea Bermúdez, Julio; García-Río, Francisco; Izquierdo Alonso, José Luis; Miravitlles, Marc; Rodríguez González-Moro, José Miguel; Soler-Cataluña, Juan José.
Affiliation
  • Alcázar Navarrete B; Servicio de Neumología, Hospital de Alta Resolución de Loja, Loja, Granada, España; CIBERES, Instituto de Salud Carlos III, Madrid, España.
  • Ancochea Bermúdez J; Servicio de Neumología, Hospital Universitario La Princesa (IIS-IP), Universidad Autónoma de Madrid, Madrid, España.
  • García-Río F; Servicio de Neumología, Hospital Universitario La Paz-IdiPAZ, CIBERES, Madrid, España.
  • Izquierdo Alonso JL; Servicio de Neumología, Hospital Universitario de Guadalajara, Guadalajara, España; Departamento de Medicina, Universidad de Alcalá, Madrid, España.
  • Miravitlles M; Servicio de Neumología, Hospital Universitari Vall d'Hebron, Barcelona, España.
  • Rodríguez González-Moro JM; Servicio de Neumología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España.
  • Soler-Cataluña JJ; Servicio de Neumología, Hospital Arnau de Vilanova-Lliria, Valencia, España. Electronic address: jjsoler@telefonica.net.
Arch Bronconeumol (Engl Ed) ; 55(9): 478-487, 2019 Sep.
Article in En, Es | MEDLINE | ID: mdl-30967279
ABSTRACT

OBJECTIVE:

To describe an evidence- and experience-based expert consensus on the most relevant issues of patients with COPD exacerbations.

METHODS:

The Delphi technique was used. Evidence was reviewed by a scientific committee and 60 experts. A questionnaire was prepared containing 3 sections diagnosis of the exacerbator; treatment, and healthcare processes. The survey was answered in 2 rounds by 60 pneumologists on an online platform. Statements were scored on a Likert scale from 1 (total disagreement) to 9 (total agreement). Agreement and disagreement were defined as a score of 7-9 or 1-3, respectively, given by more than two thirds of the participants.

RESULTS:

A total of 48 statements were included, one of which was added in the second round. Consensus was reached in 37 items (78.7%) after the first round (agreement), and in 43 (89.5%) after the second round (42 agreement, 1 disagreement). The statements with the highest proportion of experts agreeing were as follows in exacerbators, chronic bronchial infection favors lung function decline (93.1%); long-acting bronchodilators should not be withdrawn (93.1%); treatment must be personalized if new exacerbations occur despite optimal bronchodilator treatment (96.6%); management must be coordinated between primary care and the respiratory medicine department (93.1%), and patients must be followed up in specific integrated multicomponent programs (94.8%).

CONCLUSIONS:

The findings of this study could assist in the diagnosis and treatment of COPD exacerbators in our area.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Disease, Chronic Obstructive Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En / Es Journal: Arch Bronconeumol (Engl Ed) Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Disease, Chronic Obstructive Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En / Es Journal: Arch Bronconeumol (Engl Ed) Year: 2019 Document type: Article